MICKLE TRAVIS C (President & CEO) purchased 17.1% of their position (5K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $44.6K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/30/2021ACC: 0001437749-21-021199
DirectorOfficer10% Owner· President & CEO
Since Oct 2018
+5K
Net shares
Net buyer
$44.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$8.92
Trade value
$44.61K
% of position
17.1%
8/30/2021
29.27K→34.27K
Total
Net shares
+5K
Net value
$44.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/30/2021 | P · Purchase | +5K | $8.92 | $44.61K | 17.1% | 29.27K | 34.27K |
| Total | +5K | $44.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned9.82K
Common Stock
IndirectShares owned1.03K
Common Stock
IndirectShares owned96.15K
Common Stock
IndirectShares owned15.24K
Total
122.25K indirect122.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.82K | Indirect |
| Common Stock | 1.03K | Indirect |
| Common Stock | 96.15K | Indirect |
| Common Stock | 15.24K | Indirect |
| Total | 122.25K | 122.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported